Recurrent syncope with a type 1 Brugada electrocardiogram pattern in a patient on amitriptyline: Brugada syndrome vs. phenocopy-a case report.
- 1Department of Cardiology, University Hospital Waterford, Dunmore Road, Waterford, X91 ER8E, Ireland.
Abstract
Background
Brugada syndrome is an inherited arrhythmogenic channelopathy associated with an increased risk of sudden cardiac death. Diagnosis relies on the presence of a spontaneous type 1 Brugada pattern on electrocardiogram (ECG). While multiple hypotheses have been proposed to explain its underlying mechanism, it is generally thought to be secondary to defective myocardial sodium channels. For this reason, sodium channel-blocking medications can induce a type 1 Brugada pattern, which may complicate risk stratification and raise the possibility of Brugada phenocopy.Case summary
A 44-year-old man on regular amitriptyline 75 mg for anxiety and panic disorder presented with two episodes of syncope. ECG showed classical features of a type 1 Brugada pattern. Routine blood investigations, including full blood count, renal function tests, a comprehensive electrolyte panel, and high-sensitivity troponin, were normal. Transthoracic echocardiography revealed normal cardiac structure and function. Following multidisciplinary team (MDT) discussion, and guided by the 2022 European Society of Cardiology (ESC) guidelines, a shared decision was made to proceed with implantable cardioverter-defibrillator (ICD) implantation. The patient was discharged with follow-up in the arrhythmia clinic and referred for genetic testing.Discussion
This case highlighted the diagnostic and management challenges of differentiating true Brugada syndrome from drug-induced Brugada phenocopy. Although our patient had type 1 Brugada ECG pattern in the context of amitriptyline use, his presentation with syncope complicates risk stratification. MDT discussion and reference to ESC guidelines played a key role in determining further management, which in this case was ICD implantation.
Related
- Posterior Cortical Atrophy Phenocopy Associated with Antiphospholipid Syndrome: A Case Report
- Recurrent Syncope Due to Orthostatic Hypotension Following Lateral Medullary Infarction: A Case Report
- Isolated Recurrent Syncope as the Initial Presentation of Pheochromocytoma: A Case Report of a Hidden Catecholamine-Secreting Tumor
- Unexplained Syncope in Patients With Congenital Long QT Syndrome ― Role of Implantable Loop Recorders in Diagnostic Evaluation ―
- Remote Acute Coronary Syndrome Chest Pain Triage by Electrocardiogram and Cardiac Biomarker Using Telemedicine
BibTeX
@article{asyraf2026recurrent,
title = {{Recurrent syncope with a type 1 Brugada electrocardiogram pattern in a patient on amitriptyline: Brugada syndrome vs. phenocopy-a case report.}},
author = {Muhammad K Asyraf and Philip Smyth and Sajjad Matiullah},
journal = {European heart journal. Case reports},
year = {2026},
month = sep,
doi = {10.1093/ehjcr/ytag710},
url = {https://europepmc.org/article/MED/42910193},
note = {CC BY},
}
RIS
TY - JOUR
TI - Recurrent syncope with a type 1 Brugada electrocardiogram pattern in a patient on amitriptyline: Brugada syndrome vs. phenocopy-a case report.
AU - Muhammad K Asyraf
AU - Philip Smyth
AU - Sajjad Matiullah
PY - 2026
DA - 2026/09/26
JO - European heart journal. Case reports
DO - 10.1093/ehjcr/ytag710
UR - https://europepmc.org/article/MED/42910193
AB - Background Brugada syndrome is an inherited arrhythmogenic channelopathy associated with an increased risk of sudden cardiac death. Diagnosis relies on the presence of a spontaneous type 1 Brugada pattern on electrocardiogram (ECG). While multiple hypotheses have been proposed to explain its underlying mechanism, it is generally thought to be secondary to defective myocardial sodium channels. For this reason, sodium channel-blocking medications can induce a type 1 Brugada pattern, which may complicate risk stratification and raise the possibility of Brugada phenocopy.Case summary A 44-year-old man on regular amitriptyline 75 mg for anxiety and panic disorder presented with two episodes of syncope. ECG showed classical features of a type 1 Brugada pattern. Routine blood investigations, including full blood count, renal function tests, a comprehensive electrolyte panel, and high-sensitivity troponin, were normal. Transthoracic echocardiography revealed normal cardiac structure and function. Following multidisciplinary team (MDT) discussion, and guided by the 2022 European Society of Cardiology (ESC) guidelines, a shared decision was made to proceed with implantable cardioverter-defibrillator (ICD) implantation. The patient was discharged with follow-up in the arrhythmia clinic and referred for genetic testing.Discussion This case highlighted the diagnostic and management challenges of differentiating true Brugada syndrome from drug-induced Brugada phenocopy. Although our patient had type 1 Brugada ECG pattern in the context of amitriptyline use, his presentation with syncope complicates risk stratification. MDT discussion and reference to ESC guidelines played a key role in determining further management, which in this case was ICD implantation.
SN - 2514-2119
ER -